These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 10779485)

  • 1. Congenic mapping of the type 1 diabetes locus, Idd3, to a 780-kb region of mouse chromosome 3: identification of a candidate segment of ancestral DNA by haplotype mapping.
    Lyons PA; Armitage N; Argentina F; Denny P; Hill NJ; Lord CJ; Wilusz MB; Peterson LB; Wicker LS; Todd JA
    Genome Res; 2000 Apr; 10(4):446-53. PubMed ID: 10779485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic dissection of type 1 diabetes susceptibility gene, Idd3, by ancestral haplotype congenic mapping.
    Ikegami H; Fujisawa T; Makino S; Ogihara T
    Ann N Y Acad Sci; 2002 Apr; 958():325-8. PubMed ID: 12021134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of protective IL-2 allelic variants on CD4+ Foxp3+ regulatory T cell function in situ and resistance to autoimmune diabetes in NOD mice.
    Sgouroudis E; Albanese A; Piccirillo CA
    J Immunol; 2008 Nov; 181(9):6283-92. PubMed ID: 18941219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mapping of the IDDM locus Idd3 to a 0.35-cM interval containing the interleukin-2 gene.
    Denny P; Lord CJ; Hill NJ; Goy JV; Levy ER; Podolin PL; Peterson LB; Wicker LS; Todd JA; Lyons PA
    Diabetes; 1997 Apr; 46(4):695-700. PubMed ID: 9075813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonobese diabetic congenic strain analysis of autoimmune diabetes reveals genetic complexity of the Idd18 locus and identifies Vav3 as a candidate gene.
    Fraser HI; Dendrou CA; Healy B; Rainbow DB; Howlett S; Smink LJ; Gregory S; Steward CA; Todd JA; Peterson LB; Wicker LS
    J Immunol; 2010 May; 184(9):5075-84. PubMed ID: 20363978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Idd1 and Idd3 are necessary but not sufficient for development of type 1 diabetes in NOD mouse.
    Ikegami H; Fujisawa T; Sakamoto T; Makino S; Ogihara T
    Diabetes Res Clin Pract; 2004 Dec; 66 Suppl 1():S85-90. PubMed ID: 15563987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential IL-21 signaling in APCs leads to disparate Th17 differentiation in diabetes-susceptible NOD and diabetes-resistant NOD.Idd3 mice.
    Liu SM; Lee DH; Sullivan JM; Chung D; Jäger A; Shum BO; Sarvetnick NE; Anderson AC; Kuchroo VK
    J Clin Invest; 2011 Nov; 121(11):4303-10. PubMed ID: 22019586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SNPs upstream of the minimal promoter control IL-2 expression and are candidates for the autoimmune disease-susceptibility locus Aod2/Idd3/Eae3.
    del Rio R; Noubade R; Subramanian M; Saligrama N; Diehl S; Rincon M; Teuscher C
    Genes Immun; 2008 Mar; 9(2):115-21. PubMed ID: 18200031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Congenic mapping and candidate sequencing of susceptibility genes for Type 1 diabetes in the NOD mouse.
    Ikegami H; Fujisawa T; Makino S; Ogihara T
    Ann N Y Acad Sci; 2003 Nov; 1005():196-204. PubMed ID: 14679059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic interactions among Idd3, Idd5.1, Idd5.2, and Idd5.3 protective loci in the nonobese diabetic mouse model of type 1 diabetes.
    Lin X; Hamilton-Williams EE; Rainbow DB; Hunter KM; Dai YD; Cheung J; Peterson LB; Wicker LS; Sherman LA
    J Immunol; 2013 Apr; 190(7):3109-20. PubMed ID: 23427248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Congenic mapping of the diabetogenic locus Idd4 to a 5.2-cM region of chromosome 11 in NOD mice: identification of two potential candidate subloci.
    Grattan M; Mi QS; Meagher C; Delovitch TL
    Diabetes; 2002 Jan; 51(1):215-23. PubMed ID: 11756344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance alleles at two non-major histocompatibility complex-linked insulin-dependent diabetes loci on chromosome 3, Idd3 and Idd10, protect nonobese diabetic mice from diabetes.
    Wicker LS; Todd JA; Prins JB; Podolin PL; Renjilian RJ; Peterson LB
    J Exp Med; 1994 Nov; 180(5):1705-13. PubMed ID: 7964456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mapping the diabetes polygene Idd3 on mouse chromosome 3 by use of novel congenic strains.
    Lord CJ; Bohlander SK; Hopes EA; Montague CT; Hill NJ; Prins JB; Renjilian RJ; Peterson LB; Wicker LS; Todd JA
    Mamm Genome; 1995 Sep; 6(9):563-70. PubMed ID: 8535060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amino acid polymorphisms altering the glycosylation of IL-2 do not protect from type 1 diabetes in the NOD mouse.
    Kamanaka M; Rainbow D; Schuster-Gossler K; Eynon EE; Chervonsky AV; Wicker LS; Flavell RA
    Proc Natl Acad Sci U S A; 2009 Jul; 106(27):11236-40. PubMed ID: 19549859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-wide microarray expression analysis of CD4+ T Cells from nonobese diabetic congenic mice identifies Cd55 (Daf1) and Acadl as candidate genes for type 1 diabetes.
    Irie J; Reck B; Wu Y; Wicker LS; Howlett S; Rainbow D; Feingold E; Ridgway WM
    J Immunol; 2008 Jan; 180(2):1071-9. PubMed ID: 18178847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Congenic mapping of the insulin-dependent diabetes (Idd) gene, Idd10, localizes two genes mediating the Idd10 effect and eliminates the candidate Fcgr1.
    Podolin PL; Denny P; Lord CJ; Hill NJ; Todd JA; Peterson LB; Wicker LS; Lyons PA
    J Immunol; 1997 Aug; 159(4):1835-43. PubMed ID: 9257847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Localization of two insulin-dependent diabetes (Idd) genes to the Idd10 region on mouse chromosome 3.
    Podolin PL; Denny P; Armitage N; Lord CJ; Hill NJ; Levy ER; Peterson LB; Todd JA; Wicker LS; Lyons PA
    Mamm Genome; 1998 Apr; 9(4):283-6. PubMed ID: 9530623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a structurally distinct CD101 molecule encoded in the 950-kb Idd10 region of NOD mice.
    Penha-Gonçalves C; Moule C; Smink LJ; Howson J; Gregory S; Rogers J; Lyons PA; Suttie JJ; Lord CJ; Peterson LB; Todd JA; Wicker LS
    Diabetes; 2003 Jun; 52(6):1551-6. PubMed ID: 12765969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic control of diabetogenesis in NOD/Lt mice. Development and analysis of congenic stocks.
    Prochazka M; Serreze DV; Worthen SM; Leiter EH
    Diabetes; 1989 Nov; 38(11):1446-55. PubMed ID: 2576007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alleles from chromosomes 1 and 3 of NOD mice combine to influence Sjögren's syndrome-like autoimmune exocrinopathy.
    Brayer J; Lowry J; Cha S; Robinson CP; Yamachika S; Peck AB; Humphreys-Beher MG
    J Rheumatol; 2000 Aug; 27(8):1896-904. PubMed ID: 10955330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.